Ovarian cancer cell lines with high EpCAM expression have been shown to be resistant to T-cell-mediated killing; however, following incubation with solitomab (1 μg/mL), they became highly sensitive to T-cell-mediated killing [99]. The gene discussed is EPCAM; the disease is ovarian cancer.